Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 58.08

+0.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (21413)	9/22/2006 3:37:04 PM
From: rkrw	Read Replies (3) of 52153

Results were in platinum resistant patients, which makes the data pretty impressive imo. I think anormed sold out a chunk of the royalty too cheap by the way and kind of a silly PR too: <<This partial monetization has provided approximately $0.25 per share in cash while maintaining a significant financial interest in the potential future success of picoplatin.">> 0.25 cents per share in cash, wow! :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next